Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
2624195
Reference Type
Journal Article
Subtype
Abstract
Title
The protective role of hydrogen sulfide in attenuating particulate matter-induced endothelial barrier disruption
Author(s)
Wang, T; Zaidi, SR, SR; Moreno-Vinasco, L; Wang, L; Lang, GD; Natarajan, V; Garcia, JGN
Year
2010
Is Peer Reviewed?
Yes
Journal
American Journal of Respiratory and Critical Care Medicine
ISSN:
1073-449X
EISSN:
1535-4970
Volume
181
Page Numbers
A1150
Language
English
DOI
10.1164/ajrccm-conference.2010.181.1_MeetingAbstracts.A1150
Web of Science Id
WOS:000208771000151
Relationship(s)
is part of a larger document
3452678
Proceedings of the American Thoracic Society 2010 International Conference, May 14-19, 2010, New Orleans
Abstract
BACKGROUND: Particulate air pollution is known to be associated with cardiopulmonary morbidity and mortality. We recently demonstrated that particulate matter (PM) exposure triggers massive oxidative stress in endothelial cells (EC), further disrupting endothelial integrity and producing lung vascular hyperpermeability. Recently evidence has implicated that the endogenous gasotransmitter, hydrogen sulfide (H2S), in a very similar pattern as nitric oxide, exerts activity as a novel endothelial cell–derived relaxing factor (EDRF) and likely participates in endothelial functional regulation and protection.
OBJECTIVE: We hypothesize that H2S, an endogenous gaseous molecule in the circulation, protects against PM-induced endothelial barrier disruption and pulmonary inflammation.
METHODS: Changes in human lung EC monolayer permeability reflected by Transendothelial Electrical Resistance (TER) were measured. Reactive oxygen species (ROS) generation and murine pulmonary inflammatory responses were studied with the exposure to PM and NaSH, an accepted H2S donor.
RESULTS: Like the ROS scavenger N-acetyl cysteine (NAC, 5 mM), NaSH (10 µM) significantly reduces PM-induced ROS in EC and further inhibits oxidative activation of p38 MAP kinase, which induces stress fiber and paracellular gap formation in ECs. In parallel, we observed that NaSH (10 µM) activates Akt, which contributes to protect endothelial integrity against PM challenge. Both pathways contribute to the EC barrier integrity afforded by H2S in PM-induced EC barrier disruption. Furthermore, NaSH (20 mg/kg, intraperitoneal injection, 30 min pretreatment) reduced intratracheal PM challenge-induced vascular protein leak, inflammatory leukocyte infiltration, and proinflammatory cytokine release in a murine model.
CONCLUSIONS: These data suggest a protective role of H2S in vascular integrity, pulmonary inflammation and remodeling against PM, and provide the basis for the development of novel H2S-related therapeutic candidates for pulmonary inflammation. This study is supported by Environmental Protection Agency/Johns Hopkins Particulate Matter Center Grant # RD83241701 (JGNG) and NIH HL058064 (JGNG).
Conference Name
American Thoracic Society 2010 International Conference
Conference Location
New Orleans, LA
Conference Dates
May 14-19, 2010
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity